RSS Atom • ISSN 1472-4683 • Subscribe • About
2006
- Dear Doctor letter issued in the U.S. relating to 14 reports of intracranial haemorrhage (ICH) events with tipranavir/r Treatment alerts - 3 August 2006
- 15th International Drug Resistance Workshop, 13-17 June 2006, Sitges, Spain Conference reports - Resistance - Conference index - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Resistance implications of monotherapy with lopinavir/r (Kaletra) Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Ritonavir reduces virological failure and resistance in treatment naïve patients treated with atazanavir Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Resistance to darunavir (TMC-114): predicting responses for treatment experienced patients Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Epidemiological studies and transmission of resistance: evidence for optimism – or issues with interpretation? Conference reports - Resistance - Transmission and prevention - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- K103N containing variants persist longer in women with subtype D and with higher viral loads Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- No subtype-based differences in baseline levels of K103N-containing variants in women receiving single dose nevirapine Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Phenotypic NNRTI resistance and genetic diversity in antiretroviral naïve women Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- High prevalence of the K65R mutation in Botswana patients treated with ddI/d4T-based regimens Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Potential for easier selection of K65R mutation with tenofovir pressure in subtype C HIV-1 isolates Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Categorisation of transmitted HIV drug resistance using the WHO/CDC HIV drug resistance threshold survey method may be useful in resource limited settings Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Limitations in online tools to identify HIV-1 subtypes Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Resistance implications from PrEP and microbicide studies in macaques Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Low-level resistance linked to treatment failure: a role for more sensitive testing for naïve patients Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Testing for resistance after starting treatment Conference reports - Resistance - Intl Drug Resistance Workshop 15 Sitges 2006 - 3 August 2006
- Activists meet with Gilead and Abbott over access to second-line therapy Treatment access - 3 August 2006
- Efficacy of treatment of acute hepatiitis C in patients with HIV infection Hepatitis coinfection - 3 August 2006
- HIV transmission, the law and the work of the clinical team: draft recommendations for comment Other news - 3 August 2006
- FDA adds last minute clause into package of patient reforms that protects pharmaceutical industry from litigation in cases of side effects Other news - 3 August 2006
- 7th International Workshop on Clinical Pharmacology of HIV Therapy, 20-22 April 2006, Lisbon Conference reports - Conference index - PK Workshop 7th 2006 - 11 June 2006
- Pharmacokinetics for generic fixed dose combinations for children are comparable to the branded products Conference reports - Paediatric care - PK Workshop 7th 2006 - 11 June 2006
- Caution against dividing adult FDCs (Triomune) for young children Conference reports - Paediatric care - PK Workshop 7th 2006 - 11 June 2006
- University of Liverpool audit of paediatric TDM Conference reports - Paediatric care - PK Workshop 7th 2006 - 11 June 2006
- Age-dependent pharmacokinetics of 3TC in children Conference reports - Paediatric care - PK Workshop 7th 2006 - 11 June 2006
- Use of small sample drug level monitoring for paediatric PI concentrations Conference reports - Paediatric care - PK Workshop 7th 2006 - 11 June 2006
- Intracellular and plasma measurements of AZT and 3TC and their metabolites in neonates Conference reports - Paediatric care - PK Workshop 7th 2006 - 11 June 2006
- Effect of pregnancy on PK of protease inhibitors Conference reports - PMTCT and maternal health - PK Workshop 7th 2006 - 11 June 2006
- Using enzyme inducers to reduce the half-life of nevirapine Conference reports - PK Workshop 7th 2006 - 11 June 2006
- Relationship between nevirapine concentrations and virological failure in a clinical setting Conference reports - PK and drug interactions - PK Workshop 7th 2006 - 11 June 2006
- Summary of drug interaction studies Conference reports - PK and drug interactions - PK Workshop 7th 2006 - 11 June 2006
- Effects of ketoconazole and rifampin on TMC278 Conference reports - PK and drug interactions - PK Workshop 7th 2006 - 10 June 2006
- Brecanavir interaction study with ritonavir and atazanavir Conference reports - PK and drug interactions - PK Workshop 7th 2006 - 10 June 2006
- Autologous stem cells transplant (ASCT) in HIV-positive individuals with a relapsed non-Hodgkin’s lymphoma (NHL) or Hodgkin’s disease (HD) Special reports - Treatment strategies - 10 June 2006
- Community opposition filed against tenofovir patent application in India Treatment access - 10 June 2006
- LGV in the UK: almost 350 cases reported and still predominantly affecting HIV-positive gay men Other news - BHIVA 12th Brighton 2006 - 10 June 2006
- Letter from Sir Liam Donaldson to all Chief Executives of Primary Care Trusts and Strategic Health Authorities in England Other news - Special reports - 24 May 2006
- 12th Annual Conference of the British HIV Association, 29 March–1 April 2006, Brighton Conference reports - BHIVA 12th Brighton 2006 - Conference index - 12 May 2006
- HIV in the UK – summaries from BHIVA 12th annual conference Conference reports - BHIVA 12th Brighton 2006 - 12 May 2006
- Primary care practice still fails to diagnose HIV patients from high-risk groups or with symptomatic acute infection Conference reports - BHIVA 12th Brighton 2006 - 12 May 2006
- Use of HLA-B*5701 genetic testing to reduce abacavir hypersensitivity reactions Conference reports - Side effects - BHIVA 12th Brighton 2006 - 12 May 2006
- Dosing rifabutin and lopinavir/r – sub-optimal rifabutin levels reported in five patients dosed according to current guidelines Conference reports - PK and drug interactions - TB coinfection - BHIVA 12th Brighton 2006 - 12 May 2006
- Fatal seronegative visceral leishmaniasis in Portuguese patient Conference reports - Opportunistic infections and complications - BHIVA 12th Brighton 2006 - 12 May 2006
- Awareness of PEP after sexual exposure (PEPSE) Conference reports - BHIVA 12th Brighton 2006 - 12 May 2006
- Final reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver Conference reports - Conference index - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Regimen durability and toxicity in 36-month follow up on ART in Khayelitsha, South Africa Conference reports - Side effects - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Adults in resource-limited settings are most likely to experience an HIV-associated Illness in the first three months from initiating therapy Conference reports - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Causes of death in adults receiving ARV therapy in Senegal Conference reports - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Rapid scale-up of treatment in Zambia delivered at primary health level Conference reports - CROI 13 (Retrovirus) 2006 - 12 May 2006
- The effect of HIV subtype on disease progression in Rakai, Uganda Conference reports - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Genital tract pharmacokinetics of ten antiretroviral drugs in HIV-positive women Conference reports - Women's health - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Initiation of ART leads to a rapid decline in cervical and vaginal HIV-1 RNA Conference reports - Women's health - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Effect of HSV-2 treatment on HIV-1 genital shedding and plasma viral load Conference reports - Women's health - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Once-daily FTC, ddI, and efavirenz in children and adolescents Conference reports - Paediatric care - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Simplified triple NRTI regimen effective in vertically infected children: two years follow-up Conference reports - Paediatric care - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Long-term clinical and biological outcomes in children vertically infected with HIV Conference reports - Paediatric care - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Prospective follow up of children with lipodystrophy Conference reports - Paediatric care - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Tuberculosis in HIV-positive children often missed from incidence data: the influence of HAART on paediatric TB Conference reports - Paediatric care - TB coinfection - CROI 13 (Retrovirus) 2006 - 12 May 2006
- Nevirapine pharmacokinetics with infant prophylaxis Conference reports - Paediatric care - CROI 13 (Retrovirus) 2006 - 12 May 2006